Cardiovascular disease—the world's leading cause of death—is increasingly driven by air pollution, toxic chemicals, plastics, and extreme temperatures.| U.S. Right to Know
Antiphospholipid antibodies (phospholipid are fat molecules) were seen to increase the likelihood of heart disease or the like with SLE.| Lupus News Today
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of […] The post Common arthritis drug reveals hidden benefit appeared first on News.| News
“When you live in a black and white world, and everything has to be good or bad, and natural is good and not natural is bad, and you are a robot, life is a painful place to exist.” —Peter Attia The post #361 – AMA #74: Sugar and sugar substitutes: weight control, metabolic effects, and health trade-offs appeared first on Peter Attia.| Peter Attia
“The ovary and the thymus. We call them the canary in the coal mine.” —Eric Verdin The post #359 ‒ How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more | Eric Verdin, M.D. appeared first on Peter Attia.| Peter Attia
Eli Lilly and Co. has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion, in a move that bolsters Lilly's push into gene editing for cardiovascular conditions and signals renewed confidence in the sector.| Drug Discovery and Development
Resting heart rate, HRV, heart rate recovery, VO₂ max, and blood pressure—how to measure and interpret them, why they matter, and what you can do to improve them The post Understanding and improving important cardiovascular metrics appeared first on Peter Attia.| Peter Attia
The first half of 2025 has been remarkably productive for our continuing medical education initiatives.| Cardiometabolic Health Congress
New research suggests that a mixture of herbs and spices encourage heart health by improving blood biomarkers related to heart health.| OAWHealth
The underrepresentation of women in heart research and treatment has perpetuated the widespread misconception that cardiovascular diseases are more common in men. Some women researchers in Asia have come forward to challenge that.| Asian Scientist Magazine
“When you give women information about how their bodies work, they make great decisions for themselves.” —Rachel Rubin| Peter Attia
CVD’s growing burden, new risks, and barriers to atherosclerosis prevention. Read on for practical clinical tips!| Cardiometabolic Health Congress
Tomorrow is the start of American Heart Month! According to the National Institutes of Health (NIH), heart disease is the leading cause of death for people in the United States. Studies have shown that people with disabilities are just as … Continue reading →| Collection Spotlight from the National Rehabilitation Information Center
Discover how creative partnerships between patients and healthcare teams can revolutionize care and improve cardiorenal metabolic management.| Cardiometabolic Health Congress
Dr. Mozaffarian is Dean of the Friedman School of Nutrition Science and Policy at Tufts University. As a cardiologist and epidemiologist, his research focuses on the effects of diet and lifestyle on cardiometabolic health, including… Read More| Communications
Can reducing heavy alcohol intake significantly lower cardiovascular risk, or is the damage already done?| Peter Attia
Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases.| Labiotech.eu
The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages CHICAGO, Nov.11, 2018 — Developing novel approaches to understand cardiovascular health and pre-disease is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham ... Read More| Cleveland HeartLab, Inc.